Organic cation/carnitine transporter 2 (SLC22A5) Antibody
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
Organic cation/carnitine transporter 2 (SLC22A5) Antibody is a Rabbit Polyclonal antibody for the detection of Human SLC22A5.
Documents del producto
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Organic cation/carnitine transporter 2 (SLC22A5) |
| Host | Rabbit |
| Reactivity | Human |
| Recommended Dilution | Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Purity | > 95% |
| Purification | Purified by Protein G chromatography. |
| Size 1 | 20 µg |
| Size 2 | 50 µg |
| Size 3 | 100 µg |
| Size 4 | 200 µg |
| Size 5 | 1 mg |
| Form | Liquid |
| Tested Applications | ELISA, WB, IF/ICC |
| Buffer | 0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% glycerol. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | O76082 |
| Gene ID | 6584 |
| OMIM | 212140 |
| Background | Antibody anti-SLC22A5 |
| Status | RUO |
Descripción
Related Products
SLC22A5 antibody
Ver Producto
Recombinant Human SLC22A5
Ver Producto
Solute Carrier Family 22 Member 5 (SLC22A5) Antibody
SLC22A5 Antibody is a Rabbit Polyclonal antibody against SLC22A5. Polyspecific organic cation transporters in the liver, kidney, intestine, and other organs are critical for elimination of many endogenous small organic cations as well as a wide array of drugs and environmental toxins. The encoded protein is a plasma integral membrane protein which functions both as an organic cation transporter and as a sodium-dependent high affinity carnitine transporter. The encoded protein is involved in the active cellular uptake of carnitine. Mutations in this gene are the cause of systemic primary carnitine deficiency (CDSP), an autosomal recessive disorder manifested early in life by hypoketotic hypoglycemia and acute metabolic decompensation, and later in life by skeletal myopathy or cardiomyopathy. [provided by RefSeq, Jul 2008].
Ver Producto